Aug 08, 2023 / 12:00PM GMT
Operator
Good morning, ladies and gentlemen, and welcome to Keros Therapeutics KER-012 program update. (Operator Instructions) As a reminder, this call will be recorded and a link to the recording will be available on Keros's corporate website.
I would now like to introduce your host for today's program, Justin Frantz, the company's head of investor relations. Mr. Frantz, please go ahead.
Justin Frantz - Keros Therapeutics, Inc. - IR Head
Thank you, operator. Thank you all for joining us on today's call. This slide we are sharing this morning is available on our website at kerostx.com and is also included as an exhibit in the Form 8-K that we filed with the Securities and Exchange Commission.
I would like to note that during this call, we will be making a number of forward-looking statements. Please take a moment to review our disclaimer slide on the webcast which notes that these forward-looking statements involve risks and uncertainties, many of which are beyond Keros's control. Actual results can materially differ from those expressed or implied by
Keros Therapeutics Inc to Host Conference Call Transcript
Aug 08, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers